TAP Technology
Delivering cutting-edge cardiac medical devices to clinicians since 1994.
CardioCommand Inc., headquartered in Tampa, Florida, is a pioneering medical technology company dedicated to revolutionizing cardiac care. Established in 1994, CardioCommand has established itself as a leading innovator in the field of cardiovascular health, leveraging cutting-edge advancements in medical technology to enhance patient outcomes and streamline medical procedures.
Our Mission
At CardioCommand, our mission is to empower healthcare professionals with state-of-the-art cardiac monitoring solutions, ensuring timely and accurate diagnoses while prioritizing patient comfort and well-being. We are committed to advancing the standard of care in cardiovascular medicine through innovation, integrity, and excellence.
Use the proximity of the esophagus to the heart's left atrium to maximize your clinical advantage
Our flagship products consist of transesophageal atrial pacing (TAP) systems, leveraging the proximity of the esophagus to the heart’s left atrium. This proximity enables physicians to conduct noninvasive procedures utilizing an esophageal catheter equipped with electrodes, facilitating temporary cardiac pacing, monitoring of the heart’s electrical activity, and cardioversion of specific cardiac arrhythmias.
Our Products
CardioCommand has two product lines, servicing the Cardiology Electrophysiology Testing, Cardiology Stress Testing and the Anesthesia/Surgery markets:
TAPSTRESS
Used in cardiac stress testing, TAPSTRESS provides features for accelerating the heart for nonexercise stress testing. The TAPSTRESS System also has applications in electrophysiology (EP) testing for performing both diagnostic recording and therapeutic cardioversion procedures at the bedside or in the EP lab.
TAPSYSTEM™
Used in anesthesiology / surgery, TAPSYSTEM™ provides cardiac pacing and esophageal ECG monitoring during and after surgery.
What Sets Us Apart
CardioCommand’s products have 8 key product benefits that differentiate them from existing technologies, primarily drug methods or invasive pacing methods:
Better heart rate control
from the use of an esophageal catheter and stimulus generator that enables the physician to raise the heart rate to the desired rate within seconds, compared to the various and delayed responses that alternative drug and other temporary pacing methods produce
Increased accuracy with clearer heart images
is achieved during nonexercise cardiac stress echo testing by using TAPSTRESS as compared to the commonly used cardiac stress drugs;
Few side effects
occur with TAP products, unlike drug methods, that often cause too rapid or too slow of a heart rate, serious arrhythmias, hypo and hypertension, dry mouth, restlessness, delirium, nausea, urinary obstruction, etc.
Faster, better cardiac stress levels
are reached in seconds vs. many minutes for drug methods, and the patient does not require a long recovery period, as is required with drugs (~30 minutes) to ensure that the drug effects are gone after stress testing
Safer, noninvasive TAP
does not require any invasive surgical or intravascular procedures or significantly alter the body's chemistry as with drugs
Cost-effective
because TAP is priced competitively with other methods and yet has many added benefits - fewer side effects, less time, more rapid response, etc. - benefits that mean less cost in use than drugs or other pacing methods, including expensive and risky intravascular catheterization
Easier to use
because the TAP procedure is noninvasive and involves only a few steps
Portability and compact size
allow TAP to be performed anywhere in the hospital, including the patient's room, or on an outpatient basis, increasing convenience and reducing the use of expensive hospital resources such as EP labs and stress labs. Nonexercise stress testing can now even be safely done in the physician's office; improving availability and potentially physician reimbursement.